Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,366Revenue $M1,839Net Margin (%)4.4Z-Score3.4
Enterprise Value $M3,270EPS $0.5Operating Margin %8.1F-Score6
P/E(ttm))43.6Cash Flow Per Share $1.2Pre-tax Margin (%)6.8Higher ROA y-yN
Price/Book3.810-y EBITDA Growth Rate %31.0Quick Ratio1.4Cash flow > EarningsY
Price/Sales1.85-y EBITDA Growth Rate %4.0Current Ratio2.3Lower Leverage y-yY
Price/Cash Flow12.5y-y EBITDA Growth Rate %-7.8ROA % (ttm)4.0Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)9.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M168ROI % (ttm)7.2Gross Margin Increase y-yN

Gurus Latest Trades with BRKR

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BRKRJoel Greenblatt 2014-06-30 Add0.24%$20.03 - $24.45
($21.66)
$ 20.03-8%Add 845.99%898,448
BRKRJoel Greenblatt 2014-03-31 Buy 0.03%$19.07 - $24.25
($21.73)
$ 20.03-8%New holding, 94974 sh.94,974
BRKRJoel Greenblatt 2013-09-30 Sold Out -0.02%$15.91 - $20.99
($19.13)
$ 20.035%Sold Out0
BRKRVanguard Health Care Fund 2013-06-30 Add0.14%$15.94 - $19.13
($17.29)
$ 20.0316%Add 307.28%3,285,758
BRKRVanguard Health Care Fund 2013-03-31 Buy 0.06%$15.238 - $19.1
($17.43)
$ 20.0315%New holding, 806758 sh.806,758
BRKRJoel Greenblatt 2012-12-31 Reduce-0.18%$11.77 - $15.54
($13.79)
$ 20.0345%Reduce -84.28%38,498
BRKRJoel Greenblatt 2012-09-30 Buy 0.21%$11.34 - $14.13
($12.66)
$ 20.0358%New holding, 244897 sh.244,897
BRKRJoel Greenblatt 2011-06-30 Sold Out -0.1%$17.36 - $21.44
($19.3)
$ 20.034%Sold Out0
BRKRJoel Greenblatt 2011-03-31 Add0.02%$16 - $20.6
($18.23)
$ 20.0310%Add 27.81%16,567
BRKRMario Gabelli 2011-03-31 Sold Out $16 - $20.6
($18.23)
$ 20.0310%Sold Out0
BRKRJoel Greenblatt 2010-12-31 Buy 0.07%$14.14 - $17.46
($15.67)
$ 20.0328%New holding, 12962 sh.12,962
BRKRGeorge Soros 2010-09-30 Sold Out $10.88 - $14.32
($12.79)
$ 20.0357%Sold Out0
BRKRGeorge Soros 2010-06-30 Buy $11.97 - $15.56
($13.77)
$ 20.0346%New holding, 11800 sh.11,800
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BRKR is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BRKR Joel Greenblatt 2014-06-30898,4480.540.27+845.99%
BRKR Vanguard Health Care Fund 2014-06-303,285,7581.960.21
Premium Most recent portfolio changes are included for Premium Members only!


BRKR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LAUKIEN FRANK HCEO/President, 10% Owner 2012-12-14Buy50,000$14.6838.01view
LAUKIEN FRANK HCEO, President, 10% Owner 2011-03-17Buy10,000$18.598.98view
LAUKIEN DIRK DDirector, 10% Owner 2011-03-14Sell936,525$18.3510.41view
LAUKIEN JOERG CDirector, 10% Owner 2011-03-14Sell936,525$18.3510.41view
LAUKIEN FRANK HCEO, President, 10% Owner 2011-03-03Buy1,220$19.493.95view
LAUKIEN FRANK HCEO, President, 10% Owner 2011-02-28Buy550$19.44.43view
LAUKIEN JOERG CDirector, 10% Owner 2010-12-13Sell926,900$16.9819.32view
LAUKIEN DIRK DDirector, 10% Owner 2010-12-13Sell926,900$16.9819.32view
STEIN RICHARD MSecretary 2010-11-19Sell2,500$15.332.42view
KNISS RICHARDDirector 2010-11-09Sell12,600$15.2432.94view

Press Releases about BRKR :

    Quarterly/Annual Reports about BRKR:

    News about BRKR:

    Articles On GuruFocus.com
    comment on BRKR Mar 23 2013 
    Weekly CEO Buys Highlight: NGL, BRKR, UTHR, KTOS, GBL Dec 24 2012 
    Bruker BioSciences Corp. (BRKR) CEO Frank H Laukien buys 10,000 Shares Mar 17 2011 
    Bruker BioSciences Corp. (BRKR) CEO Frank H Laukien buys 1,220 Shares Mar 03 2011 
    Weekly CEO Buys Highlight: Deer Consumer Products, Dynex Capital, Bruker BioSciences Corp, American Mar 27 2010 
    Weekly CEO Buys Highlight: Bruker BioSciences Corp, Dynex Capital Inc, American Dairy Inc, Pioneer D Mar 21 2010 
    Bruker BioSciences Corp. (BRKR) CEO Frank H Laukien buys 100,000 Shares Mar 18 2010 
    Bruker BioSciences Corp. (BRKR) CEO Frank H Laukien buys 100,000 Shares Mar 15 2010 
    Bruker BioSciences Corp. (BRKR) CEO Frank H Laukien buys 3,570 Shares Dec 15 2009 
    Weekly CEO Buy Highlights: Bruker BioSciences Corp, Cousins Properties Inc, FIFTH STREET FINANCE, La Sep 27 2009 

    More From Other Websites
    BRUKER CORP Financials Aug 15 2014
    Analytik Jena AG Signs Agreement to Acquire Bruker’s ICP-MS Business Aug 13 2014
    Ad Hoc Announcement in Accordance with Section 15 of the WpHG (German Securities Trading Act):... Aug 13 2014
    BRUKER CORP Files SEC form 10-Q, Quarterly Report Aug 08 2014
    3 Stocks Dragging The Electronics Industry Downward Aug 07 2014
    Bruker Reports Second Quarter 2014 Financial Results Aug 06 2014
    BRUKER CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Aug 06 2014
    Bruker Reports Second Quarter 2014 Financial Results Aug 06 2014
    Q2 2014 Bruker Corp Earnings Release - 4:00 pm ET Aug 06 2014
    Bruker Announces Acquisition of High-Speed, 3D Super-Resolution Fluorescence Microscopy Company... Jul 28 2014
    Bruker Announces Acquisition of High-Speed, 3D Super-Resolution Fluorescence Microscopy Company... Jul 28 2014
    BRUKER CORP Files SEC form 8-K, Costs Associated with Exit or Disposal Activities Jul 23 2014
    Danaher Q2 Earnings, Guidance Disappoint Wall Street Jul 17 2014
    Bruker Announces Date and Time of Second Quarter 2014 Earnings Release and Webcast Jul 17 2014
    Bruker's Inspire Mapping System Fails to Inspire Share Prices Jul 14 2014
    Bruker Introduces Inspire Nanoscale Chemical Mapping System Jul 10 2014
    Bruker Introduces Inspire Nanoscale Chemical Mapping System Jul 10 2014
    Bruker Corp. downgraded by ISI Group Jul 08 2014
    Bruker's MALDI Biotyper Approved for Biochemical Testing in China Jun 27 2014
    Bruker receives CFDA clearance for MALDI Biotyper Jun 25 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK